Annual EBITDA
-$104.58 M
+$2.05 M+1.92%
December 31, 2023
Summary
- As of February 7, 2025, OLMA annual EBITDA is -$104.58 million, with the most recent change of +$2.05 million (+1.92%) on December 31, 2023.
- During the last 3 years, OLMA annual EBITDA has fallen by -$83.13 million (-387.41%).
- OLMA annual EBITDA is now -4739.61% below its all-time high of -$2.16 million, reached on December 31, 2018.
Performance
OLMA EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
Quarterly EBITDA
-$37.53 M
-$4.09 M-12.23%
September 30, 2024
Summary
- As of February 7, 2025, OLMA quarterly EBITDA is -$37.53 million, with the most recent change of -$4.09 million (-12.23%) on September 30, 2024.
- Over the past year, OLMA quarterly EBITDA has dropped by -$14.27 million (-61.39%).
- OLMA quarterly EBITDA is now -3600.79% below its all-time high of -$1.01 million, reached on December 31, 2019.
Performance
OLMA Quarterly EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
TTM EBITDA
-$135.54 M
-$14.27 M-11.77%
September 30, 2024
Summary
- As of February 7, 2025, OLMA TTM EBITDA is -$135.54 million, with the most recent change of -$14.27 million (-11.77%) on September 30, 2024.
- Over the past year, OLMA TTM EBITDA has dropped by -$34.16 million (-33.70%).
- OLMA TTM EBITDA is now -13266.96% below its all-time high of -$1.01 million, reached on December 31, 2019.
Performance
OLMA TTM EBITDA Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Highlights
High & Low
Earnings dates
EBITDA Formula
EBITDA = Net Income + Interest + Taxes + Depreciation + Amortization
OLMA EBITDA Trends
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly | TTMTTM |
|---|---|---|---|
| 1 y1 year | +1.9% | -61.4% | -33.7% |
| 3 y3 years | -387.4% | -61.4% | -33.7% |
| 5 y5 years | -4739.6% | -61.4% | -33.7% |
OLMA EBITDA Highs & Lows
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | TTM vs highTTM vs high | TTM vs lowTTM vs low | |
|---|---|---|---|---|---|---|---|
| 3 y | 3-year | -46.6% | +1.9% | -74.5% | at low | -90.0% | at low |
| 5 y | 5-year | -2328.2% | +1.9% | -3600.8% | at low | <-9999.0% | at low |
| alltime | all time | -4739.6% | +1.9% | -3600.8% | at low | <-9999.0% | at low |
Olema Pharmaceuticals EBITDA History
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Sep 2024 | - | -$37.53 M(+12.2%) | -$135.54 M(+11.8%) |
| Jun 2024 | - | -$33.44 M(-2.4%) | -$121.27 M(+10.9%) |
| Mar 2024 | - | -$34.25 M(+12.9%) | -$109.33 M(+4.5%) |
| Dec 2023 | -$104.58 M(-1.9%) | -$30.33 M(+30.4%) | -$104.58 M(+3.2%) |
| Sep 2023 | - | -$23.25 M(+8.1%) | -$101.38 M(+0.1%) |
| Jun 2023 | - | -$21.50 M(-27.1%) | -$101.26 M(-10.4%) |
| Mar 2023 | - | -$29.50 M(+8.8%) | -$112.96 M(+5.9%) |
| Dec 2022 | -$106.63 M | -$27.12 M(+17.3%) | -$106.63 M(+5.4%) |
| Sep 2022 | - | -$23.13 M(-30.3%) | -$101.19 M(+5.7%) |
| Jun 2022 | - | -$33.21 M(+43.3%) | -$95.77 M(+21.1%) |
| Date | Annual | Quarterly | TTM |
|---|---|---|---|
| Mar 2022 | - | -$23.17 M(+6.9%) | -$79.06 M(+10.8%) |
| Dec 2021 | -$71.33 M(+232.4%) | -$21.68 M(+22.4%) | -$71.33 M(+19.3%) |
| Sep 2021 | - | -$17.71 M(+7.4%) | -$59.77 M(+19.8%) |
| Jun 2021 | - | -$16.49 M(+6.8%) | -$49.90 M(+39.2%) |
| Mar 2021 | - | -$15.44 M(+52.5%) | -$35.86 M(+67.1%) |
| Dec 2020 | -$21.46 M(+398.2%) | -$10.13 M(+29.1%) | -$21.46 M(+73.8%) |
| Sep 2020 | - | -$7.84 M(+220.0%) | -$12.34 M(+174.2%) |
| Jun 2020 | - | -$2.45 M(+136.4%) | -$4.50 M(+119.5%) |
| Mar 2020 | - | -$1.04 M(+2.3%) | -$2.05 M(+102.3%) |
| Dec 2019 | -$4.31 M(+99.3%) | -$1.01 M | -$1.01 M |
| Dec 2018 | -$2.16 M | - | - |
FAQ
- What is Olema Pharmaceuticals annual EBITDA?
- What is the all time high annual EBITDA for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals annual EBITDA year-on-year change?
- What is Olema Pharmaceuticals quarterly EBITDA?
- What is the all time high quarterly EBITDA for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals quarterly EBITDA year-on-year change?
- What is Olema Pharmaceuticals TTM EBITDA?
- What is the all time high TTM EBITDA for Olema Pharmaceuticals?
- What is Olema Pharmaceuticals TTM EBITDA year-on-year change?
What is Olema Pharmaceuticals annual EBITDA?
The current annual EBITDA of OLMA is -$104.58 M
What is the all time high annual EBITDA for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high annual EBITDA is -$2.16 M
What is Olema Pharmaceuticals annual EBITDA year-on-year change?
Over the past year, OLMA annual EBITDA has changed by +$2.05 M (+1.92%)
What is Olema Pharmaceuticals quarterly EBITDA?
The current quarterly EBITDA of OLMA is -$37.53 M
What is the all time high quarterly EBITDA for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high quarterly EBITDA is -$1.01 M
What is Olema Pharmaceuticals quarterly EBITDA year-on-year change?
Over the past year, OLMA quarterly EBITDA has changed by -$14.27 M (-61.39%)
What is Olema Pharmaceuticals TTM EBITDA?
The current TTM EBITDA of OLMA is -$135.54 M
What is the all time high TTM EBITDA for Olema Pharmaceuticals?
Olema Pharmaceuticals all-time high TTM EBITDA is -$1.01 M
What is Olema Pharmaceuticals TTM EBITDA year-on-year change?
Over the past year, OLMA TTM EBITDA has changed by -$34.16 M (-33.70%)